Haystack Sciences Competitors and Similar CompaniesClear all

Sarepta Therapeutics's competitors and similar companies include Bluebird Bio.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Founding Date
Founding Date
1980
Founding Date
1992
Type
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Locations
Somerville, US HQ
Employees
Employees
1,31413% increase
Employees
32338% decrease
Valuation ($)
Valuation ($)
12.4 b
Valuation ($)
95.4 m

Financial

Revenue (est.)
Revenue (est.)
$2.2b (FY, 2025)
Revenue (est.)
$83.8m (FY, 2024)
Cost of goods
Cost of goods
$25.5m (FY, 2025)
Cost of goods
$89.4m (FY, 2024)
Gross profit
Gross profit
$2.2b (FY, 2025)
Gross profit
($5.6m) (FY, 2024)
Net income
Net income
($713.4m) (FY, 2025)
Net income
($240.7m) (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company